Clinical presentation of the "depression-executive dysfunction syndrome" of late life

American Journal of Geriatric Psychiatry

Volumn 10, Issue 1, 2002, Pages 98-106

  Alexopoulos, George S ^a   Kiosses, Dimitris N ^a   Klimstra, Sibel ^a   Kalayam, Balkrishna ^a   Bruce, Martha L ^a  

^a The Cornell Institute of Geriatric Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN FUNCTION; COGNITION; DEPRESSION; DEPRESSION EXECUTIVE DYSFUNCTION SYNDROME; DISABILITY; HUMAN; MAJOR CLINICAL STUDY; PARANOIA; PSYCHOMOTOR RETARDATION; RECURRENT DISEASE; RELAPSE;

EID: 0036142074     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200201000-00012     Document Type: Article

References (64)

1. Cognition and white-matter hyperintensities in older depressed adults
2. Differential mood changes following basal ganglia vs. thalamic lesions
3. Does stroke cause depression?
4. Psychomotor symptoms of depression
5. Depressive disorders following posterior circulation as compared with middle cerebral artery infarcts
6. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
7. Glial reduction in the prefrontal cortex in mood disorders
8. MRI-defined vascular depression
9. Subcortical hyperintensity in MRI: A comparison of normal and depressed elderly subjects
10. Neuroanatomic substrates of depression in the elderly
11. Neuropsychological correlates of white-matter lesions in healthy elderly subjects
12. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F] 2-deoxyglucose in affective illness
13. Reduction of cerebral blood flow in older depressed patients
14. Subgenual prefrontal cortex abnormalities in mood disorders
15. Frontal lobe dysfunction in secondary depression
16. A functional anatomical study of unipolar depression
17. Functional neuroimaging studies of depression: The anatomy of melancholia
18. Hippocampal and anterior cingulate activation in patients with geriatric depression
19. Frontal-subcortical circuits: The anatomical basis of executive, social, and motivated behaviors
20. Prefrontal dysfunction and treatment response in geriatric depression
21. Executive dysfunction increases the risk for relapse and recurrence of geriatric depression
22. White-matter hyperintensity on magnetic resonance imaging: Clinical and neuroanatomic correlates in the depressed elderly
23. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression
24. Cingulate function in depression: A potential predictor of treatment response
25. 3 agonists
26. The "vascular depression" hypothesis
27. Frontal lobe lesions and behavior
28. Research diagnostic criteria
29. A rating scale for depression
30. Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression
31. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
32. Different patterns of mnemonic deficits in the two organic dementia syndromes
33. Rating chronic medical burden in geropsychiatric practice and research: Application on the Cumulative Illness Rating Scale
34. A research- and services-oriented multi-level assessment instrument
35. The family-history method using diagnostic criteria: Reliability and validity
36. Hierarchy of characteristics associated with depressive symptoms in an urban elderly sample
37. Action of opioid drugs on the brain reward system
38. Cholinesterase inhibitors: A new class of psychotropic compounds
39. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease
40. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients
41. Cholinergic challenges in affective illness: Behavioral and neuroendocrine correlates
42. 3 receptor co-existence
43. 3 receptors: Effects of MPTP and dopamine agonist replacement therapies
44. 3 receptor function in response to psychostimulants using a genetic approach
45. Reversal of stress-induced anhedonia by the dopamine receptor agonist pramipexole
46. 3 dopamine receptor agonist
47. The mesolimbic dopamine system as a target for rapid antidepressant action
48. Pramipexole, a dopamine agonist in major depression: Antidepressant effects and tolerability in an open-label study with multiple dosages
49. Pramipexole augmentation of SSRIs in treatment-resistant major depression
50. Pramipexole, a dopamine agonist, in the treatment of major depression
51. Modafinil augmentation of antidepressant treatment in depression
52. Storage and executive processes in the frontal lobes
53. The Dementia Rating Scale in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy
54. Differentiation of Alzheimer's and Parkinson's disease with the Dementia Rating Scale
55. A PET study of word finding
56. Transition of brain activation from frontal to parietal areas in visuomotor sequence learning
57. Anatomy of motor learning, I: Frontal cortex and attention to action
58. Depressive symptoms, medical illness, and functional status in depressed psychiatric inpatients